Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
54.77
-2.41 (-4.21%)
At close: Apr 28, 2026, 4:00 PM EDT
53.68
-1.09 (-1.99%)
After-hours: Apr 28, 2026, 4:25 PM EDT
Spruce Biosciences Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Spruce Biosciences stock have an average target of 190.6, with a low estimate of 140 and a high estimate of 283. The average target predicts an increase of 248.00% from the current stock price of 54.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Spruce Biosciences stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 3 | 3 | 3 | 3 | 3 |
| Hold | 5 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $140 | Strong Buy | Initiates | $140 | +155.61% | Apr 27, 2026 |
| Citizens | Citizens | Buy Maintains $180 → $170 | Buy | Maintains | $180 → $170 | +210.39% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | +265.16% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $220 → $200 | Strong Buy | Maintains | $220 → $200 | +265.16% | Feb 19, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $283 | Buy | Initiates | $283 | +416.71% | Dec 23, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
46.62M
EPS This Year
-37.45
from -50.83
EPS Next Year
-11.46
from -37.45
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | 159.4M | |||
| Avg | n/a | 46.6M | |||
| Low | n/a | 5.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -21.26 | 12.28 | |||
| Avg | -37.45 | -11.46 | |||
| Low | -63.29 | -27.62 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.